AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹13 Cr | ₹-18 Cr | ₹8.89 Cr | ₹5.72 Cr | ₹11 Cr |
What is the latest Cash Flow from Operating Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹13 Cr |
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹8.89 Cr |
| Mar2023 | ₹5.72 Cr |
| Mar2022 | ₹11 Cr |
How is Cash Flow from Operating Activities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹13 Cr | Positive | |
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹8.89 Cr | 55.23 | |
| Mar2023 | ₹5.72 Cr | -50.10 | |
| Mar2022 | ₹11 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹334.7 Cr | -8.3% | 40.7% | 29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -8.3% |
40.7% |
29.5% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses